Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$473K Buy
6,752
+580
+9% +$30K 0.02% 421
2026
Q1
$314K Buy
6,172
+28
+0.5% +$1.31K 0.02% 434
2025
Q4
$181K Buy
+6,144
New +$167K 0.01% 490
2025
Q1
Sell
-9,475
Closed -$394K 162
2024
Q4
$394K Buy
+9,475
New +$453K 0.16% 115

Other funds holding MRNA

Tema ETFs's MRNA Position: Q2 2026 in Review

Tema ETFs increased its Moderna (MRNA) stake by 9.4% in Q2 2026, buying an estimated $30K and bringing the position to 6,752 shares worth $473K. The position accounts for 0.02% of the portfolio, ranked #421.

Tema ETFs first reported a position in MRNA in Q4 2024 and has held it in 4 quarters since. 99 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Tema ETFs held 6,752 shares of Moderna worth $473K as of Q2 2026.
  • Tema ETFs bought 580 Moderna shares in Q2 2026, an estimated $30K.
  • Moderna made up 0.02% of Tema ETFs's portfolio in Q2 2026, its #421 holding.
  • Tema ETFs first reported a position in Moderna in Q4 2024 and has held it in 4 quarters since.
  • 99 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.